v3.25.2
Condensed Consolidated Balance Sheets (Unaudited) - OMFC - USD ($)
$ in Millions
Jun. 30, 2025
Dec. 31, 2024
Assets    
Cash and cash equivalents $ 769 $ 458
Investment securities (includes available-for-sale securities with a fair value and an amortized cost basis of $1.6 billion and $1.7 billion in 2025, respectively, and $1.5 billion and $1.6 billion in 2024, respectively) 1,683 1,607
Net finance receivables (includes loans of consolidated VIEs of $14.5 billion in 2025 and $14.0 billion in 2024) 23,870 23,554
Unearned insurance premium and claim reserves (764) (766)
Allowance for finance receivable losses (includes allowance of consolidated VIEs of $1.7 billion in 2025 and $1.6 billion in 2024) (2,754) (2,705)
Net finance receivables, less unearned insurance premium and claim reserves and allowance for finance receivable losses 20,352 20,083
Restricted cash and restricted cash equivalents (includes restricted cash and restricted cash equivalents of consolidated VIEs of $720 million in 2025 and $662 million in 2024) 742 684
Goodwill 1,474 1,474
Other intangible assets 285 286
Other assets 1,323 1,318
Total assets 26,628 25,910
Liabilities and Shareholders’ Equity    
Long-term debt (includes debt of consolidated VIEs of $12.7 billion in 2025 and $12.4 billion in 2024) 22,053 21,438
Insurance claims and policyholder liabilities 579 575
Deferred and accrued taxes 18 20
Other liabilities (includes other liabilities of consolidated VIEs of $29 million in 2025 and $31 million in 2024) 652 686
Total liabilities 23,302 22,719
Contingencies (Note 12)
Shareholders’ equity:    
Common stock, par value $0.50 per share; 25,000,000 shares authorized, 10,160,021 shares issued and outstanding at June 30, 2025 and December 31, 2024 1 1
Additional paid-in capital 1,745 1,734
Accumulated other comprehensive loss (51) (81)
Retained earnings 2,425 2,296
Total shareholders’ equity 3,326 3,191
Total liabilities and shareholders’ equity 26,628 25,910
OMFC    
Assets    
Cash and cash equivalents 741 424
Investment securities (includes available-for-sale securities with a fair value and an amortized cost basis of $1.6 billion and $1.7 billion in 2025, respectively, and $1.5 billion and $1.6 billion in 2024, respectively) 1,683 1,607
Net finance receivables (includes loans of consolidated VIEs of $14.5 billion in 2025 and $14.0 billion in 2024) 23,870 23,554
Unearned insurance premium and claim reserves (764) (766)
Allowance for finance receivable losses (includes allowance of consolidated VIEs of $1.7 billion in 2025 and $1.6 billion in 2024) (2,754) (2,705)
Net finance receivables, less unearned insurance premium and claim reserves and allowance for finance receivable losses 20,352 20,083
Restricted cash and restricted cash equivalents (includes restricted cash and restricted cash equivalents of consolidated VIEs of $720 million in 2025 and $662 million in 2024) 742 684
Goodwill 1,474 1,474
Other intangible assets 285 286
Other assets 1,321 1,317
Total assets 26,598 25,875
Liabilities and Shareholders’ Equity    
Long-term debt (includes debt of consolidated VIEs of $12.7 billion in 2025 and $12.4 billion in 2024) 22,053 21,438
Insurance claims and policyholder liabilities 579 575
Deferred and accrued taxes 18 20
Other liabilities (includes other liabilities of consolidated VIEs of $29 million in 2025 and $31 million in 2024) 651 687
Total liabilities 23,301 22,720
Contingencies (Note 12)
Shareholders’ equity:    
Common stock, par value $0.50 per share; 25,000,000 shares authorized, 10,160,021 shares issued and outstanding at June 30, 2025 and December 31, 2024 5 5
Additional paid-in capital 1,989 1,978
Accumulated other comprehensive loss (51) (81)
Retained earnings 1,354 1,253
Total shareholders’ equity 3,297 3,155
Total liabilities and shareholders’ equity $ 26,598 $ 25,875